Pharming Group (PHAR)
8.333
-0.19
(-2.20%)
USD |
NASDAQ |
Nov 04, 16:00
8.40
+0.07
(+0.81%)
After-Hours: 20:00
Pharming Group Total Liabilities (Quarterly): 199.72M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 199.72M |
| June 30, 2024 | 194.99M |
| March 31, 2024 | 235.72M |
| December 31, 2023 | 244.07M |
| September 30, 2023 | 226.52M |
| June 30, 2023 | 229.43M |
| March 31, 2023 | 223.65M |
| December 31, 2022 | 221.16M |
| September 30, 2022 | 182.07M |
| June 30, 2022 | 194.23M |
| March 31, 2022 | 198.78M |
| December 31, 2021 | 204.40M |
| September 30, 2021 | 207.37M |
| June 30, 2021 | 213.86M |
| March 31, 2021 | 222.54M |
| December 31, 2020 | 235.02M |
| September 30, 2020 | 214.96M |
| June 30, 2020 | 213.17M |
| March 31, 2020 | 207.70M |
| December 31, 2019 | 138.53M |
| September 30, 2019 | 142.60M |
| June 30, 2019 | 145.88M |
| March 31, 2019 | 146.54M |
| December 31, 2018 | 174.71M |
| September 30, 2018 | 167.96M |
| Date | Value |
|---|---|
| June 30, 2018 | 162.68M |
| March 31, 2018 | 171.46M |
| December 31, 2017 | 180.05M |
| September 30, 2017 | 157.04M |
| June 30, 2017 | 137.50M |
| March 31, 2017 | 109.53M |
| December 31, 2016 | 104.45M |
| September 30, 2016 | 38.00M |
| June 30, 2016 | 39.50M |
| March 31, 2016 | 39.37M |
| December 31, 2015 | 37.00M |
| September 30, 2015 | 41.16M |
| June 30, 2015 | 24.97M |
| March 31, 2015 | 26.51M |
| December 31, 2014 | 31.46M |
| September 30, 2014 | 31.57M |
| June 30, 2014 | 39.30M |
| March 31, 2014 | 35.88M |
| December 31, 2013 | 36.45M |
| September 30, 2013 | 34.15M |
| June 30, 2013 | 38.15M |
| March 31, 2013 | 45.36M |
| December 31, 2012 | 32.40M |
| September 30, 2012 | 34.36M |
| March 31, 2012 | 41.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
138.53M
Minimum
Dec 2019
244.07M
Maximum
Dec 2023
210.40M
Average
213.52M
Median
Total Liabilities (Quarterly) Benchmarks
| uniQure NV | 633.74M |
| ProQR Therapeutics NV | 91.32M |
| Merus NV | 141.42M |
| argenx SE | -- |
| Pharvaris NV | 20.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 425.51M |
| Shareholders Equity (Quarterly) | 225.79M |
| Debt to Equity Ratio | 0.4226 |
| Current Ratio | 3.534 |
| Net Debt Paydown Yield | 1.45% |